Growth in testing Smithers is expanding its Distribution Testing laboratory in the United Kingdom with completion expected by Q4 2026, signaling capacity growth and potential for new client engagements requiring distribution and quality testing services.

Regulatory ready With GLP, GCP, and CLIA compliant laboratories and involvement in >100 clinical trials across FDA-regulated development stages, Smithers offers robust bioanalytical and method validation capabilities that can support sponsors seeking compliant CRO partnerships.

Leadership visibility Recent high profile speaking engagements and leadership appointments at industry forums (Global Polymer Summit, World Print & Communication Forum) indicate active thought leadership and strong networking potential to generate opportunities in adjacent markets and partnerships.

Strategic partnerships Active collaboration initiatives and partnerships (for example with Flexographic Association and CannaMetrix) suggest appetite for cross-industry projects, potentially opening doorways to nontraditional clients needing testing, analytics, and distribution testing expertise.

Technology enablement Adoption of a modern tech stack (Azure AI Services, Marketo, Sage Intacct, MATLAB, LinkedIn Sales Navigator) supports data-driven marketing and analytics, enabling targeted outreach to pharmaceutical sponsors and material suppliers requiring advanced bioanalytical services.